- Todos > Medicine Access and Rational Use > Controlled Medicines
- Todos > Medicine Access and Rational Use > Pricing
- Palabras clave > Access to Controlled Medications Programme
- Palabras clave > access to opioid medications
- Palabras clave > availability - opioid analgesics
- Palabras clave > cancer pain relief
- Palabras clave > controlled substances
- Palabras clave > opioid analgesics
- Palabras clave > opioids - dispensed prices, and affordability
- Palabras clave > palliative care - policy
- Palabras clave > prices - opioids
- Palabras clave > World Health Assembly - WHA resolutions
(2017; 6 pages) [Arabic] [Chinese] [French] [Russian] [Spanish]
...Aware that early diagnosis and prompt and appropriate treatment, including pain relief and palliative care, can reduce mortality and improve the outcomes and quality of life of cancer patients;
Recognizing with appreciation the introduction of new pharmaceutical products based on investment in innovation for cancer treatment in recent years, and noting with great concern the increasing cost to health systems and patients;
Emphasizing the importance of addressing barriers in access to safe, quality, effective and affordable medicines, medical products and appropriate technology for cancer prevention, detection, screening diagnosis and treatment, including surgery, by strengthening national health systems and international cooperation, including human resources, with the ultimate aim of enhancing access for patients, including through increasing the capacity of the health systems to provide such access;...
...Reaffirming the global strategy and plan of action on public health, innovation and intellectual property;
Reaffirming also the rights of Member States to the full use of the flexibilities in the WTO Agreement on Trade-related Aspects of the Intellectual Property Rights (TRIPS) to increase access to affordable, safe, effective and quality medicines, noting that, inter alia, intellectual property rights are an important incentive in the development of new health products,...
URGES Member States,...
(15) to provide pain relief and palliative care in line with resolution WHA67.19 (2014) on the strengthening of palliative care as a component of comprehensive care throughout the life course;...
(21) to promote the availability and affordability of quality, safe and effective medicines (in particular, but not limited to, those on the WHO Model List of Essential Medicines), vaccines and diagnostics for cancer;
(22) to promote access to comprehensive and cost-effective prevention, treatment and care for the integrated management of cancers including, inter alia, increased access to affordable, safe, effective and quality medicines and diagnostics and other technologies;...
REQUESTS the Director-General:...
(9) to prepare a comprehensive technical report to the Executive Board at its 144th session that examines pricing approaches, including transparency, and their impact on availability and affordability of medicines for the prevention and treatment of cancer, including any evidence of the benefits or unintended negative consequences, as well as incentives for investment in research and development on cancer and innovation of these measures, as well as the relationship between inputs throughout the value chain and price setting, financing gaps for research and development on cancer, and options that might enhance the affordability and accessibility of these medicines;...